GlassScriptPhysician profile
Amanda Rae Morgan
NPI 1275743122
$19,792.94
in general payments reported to CMS, 2019-2025
15 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $112 · 2021: $35.29 · 2022: $208 · 2023: $992 · 2024: $6,789 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,963 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,068 · Food and Beverage: $2,052 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,962.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,068.20 |
| Food and Beverage | $2,052.23 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $13,261.73 | 2022-2025 | Dupixent |
| Genzyme Corporation | $4,638.63 | 2024 | |
| Glaxosmithkline, LLC. | $799.82 | 2020-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $378.84 | 2022-2024 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.96 | 2019-2025 | Ofev |
| Genentech USA, INC. | $97.49 | 2019 | |
| Intuitive Surgical, INC. | $77.90 | 2023 | Da Vinci Surgical System |
| Novartis Pharmaceuticals Corporation | $72.81 | 2019 | |
| Advanced Respiratory, INC | $65.86 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $54.99 | 2025 | Opsumit, Uptravi |
| Baxter Healthcare | $51.02 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $41.25 | 2021-2023 | Arikayce |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.77 | 2024 | Lifevest |
| United Therapeutics Corporation | $19.05 | 2021 | |
| Genentech, INC. | $18.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.